Parmax Pharma Ltd.BSE: PARMAX

Parmax Pharma Ltd. Press Release Feb 14 2025

· Issued by Parmax Pharma Ltd. via BSE India

Filed with BSE ·

In accordance with amendments to the SEBI (LODR) Regulations, 2024 read with SEBI circular No. SEBI/HO/CFD-PoD2/CIR/P/2024/185 dated 31st December, 2024 read with BSE circular no. 20250102-4 dated 2nd January, 2025, the integrated filing of financial statements for the quarter ended on 31st December, 2024 is attached herewith.

View Attachment

6ix hasn’t read this filing yet.

Parmax Pharma Ltd. on 6ix

Story so far

Earlier from Parmax Pharma

Later from Parmax Pharma

All Parmax Pharma news releases